|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gregory RI, Chendrimada TP, Cooch N and
Shiekhattar R: Human RISC couples microRNA biogenesis and
posttranscriptional gene silencing. Cell. 123:631–640. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Huntzinger E and Izaurralde E: Gene
silencing by microRNAs: Contributions of translational repression
and mRNA decay. Nat Rev Genet. 12:99–110. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gao X, Zhao H, Diao C, Wang X, Xie Y, Liu
Y, Han J and Zhang M: miR-455-3p serves as prognostic factor and
regulates the proliferation and migration of non-small cell lung
cancer through targeting HOXB5. Biochem Biophys Res Commun.
495:1074–1080. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cao Y, Song J, Ge J, Song Z, Chen J and Wu
C: MicroRNA-100 suppresses human gastric cancer cell proliferation
by targeting CXCR7. Oncol Lett. 15:453–458. 2018.PubMed/NCBI
|
|
7
|
Kang M, Shi J, Peng N and He S:
MicroRNA-211 promotes non-small-cell lung cancer proliferation and
invasion by targeting MxA. Onco Targets Ther. 10:5667–5675. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Landgraf P, Rusu M, Sheridan R, Sewer A,
Iovino N, Aravin A, Pfeffer S, Rice A, Kamphorst AO, Landthaler M,
et al: A mammalian microRNA expression atlas based on small RNA
library sequencing. Cell. 129:1401–1414. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang P, Wang L, Rodriguez-Aguayo C, Yuan
Y, Debeb BG, Chen D, Sun Y, You MJ, Liu Y, Dean DC, et al: miR-205
acts as a tumour radiosensitizer by targeting ZEB1 and Ubc13. Nat
Commun. 5:56712014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Niu K, Shen W, Zhang Y, Zhao Y and Lu Y:
MiR-205 promotes motility of ovarian cancer cells via targeting
ZEB1. Gene. 574:330–336. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhong G and Xiong X: miR-205 promotes
proliferation and invasion of laryngeal squamous cell carcinoma by
suppressing CDK2AP1 expression. Biol Res. 48:602015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Orang AV, Safaralizadeh R, Feizi
Hosseinpour MA and Somi MH: Diagnostic and prognostic value of
miR-205 in colorectal cancer. Asian Pac J Cancer Prev.
15:4033–4037. 2015. View Article : Google Scholar
|
|
13
|
Jin C and Liang R: miR-205 promotes
epithelial-mesenchymal transition by targeting AKT signaling in
endometrial cancer cells. J Obstet Gynaecol Res. 41:1653–1660.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li J, Hao L, Wu J, Zhang J and Su J:
Linarin promotes osteogenic differentiation by activating the
BMP-2/RUNX2 pathway via protein kinase A signaling. Int J Mol Med.
37:901–910. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kayed H, Jiang X, Keleg S, Jesnowski R,
Giese T, Berger MR, Esposito I, Löhr M, Friess H and Kleeff J:
Regulation and functional role of the Runt-related transcription
factor-2 in pancreatic cancer. Br J Cancer. 97:1106–1115. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lin QJ, Yang F, Jin C and Fu DL: Current
status and progress of pancreatic cancer in China. World J
Gastroenterol. 21:7988–8003. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen W, Zheng R, Zhang S, Zhao P, Zeng H
and Zou X: Report of cancer incidence and mortality in China, 2010.
Ann Transl Med. 2:612014.PubMed/NCBI
|
|
19
|
Calin GA, Dumitru CD, Shimizu M, Bichi R,
Zupo S, Noch E, Aldler H, Rattan S, Keating M, Rai K, et al:
Frequent deletions and down-regulation of micro-RNA genes miR15 and
miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci
USA. 99:15524–15529. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chitkara D, Mittal A and Mahato RI: miRNAs
in pancreatic cancer: Therapeutic potential, delivery challenges
and strategies. Adv Drug Deliv Rev. 81:34–52. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shi M, Xie D, Gaod Y and Xie K: Targeting
miRNAs for pancreatic cancer therapy. Curr Pharm Des. 20:5279–5286.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bouchie A: First microRNA mimic enters
clinic. Nat Biotechnol. 31:5772013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Orang AV, Safaralizadeh R and Feizi
Hosseinpour MA: Insights into the diverse roles of miR-205 in human
cancers. Asian Pac J Cancer Prev. 15:577–583. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chaudhary AK, Mondal G, Kumar V, Kattel K
and Mahato RI: Chemosensitization and inhibition of pancreatic
cancer stem cell proliferation by overexpression of microRNA-205.
Cancer Lett. 402:1–8. 2017. View Article : Google Scholar : PubMed/NCBI
|
